# Task E13: Lead Optimization Screening Assays for ADMET, Safety Profiling, Rodent Pharmacokinetics and MTD

> **NIH NIH N01** · EUROFINS PANLABS, INC. · 2024 · $46,800

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 11084262
- **Project number:** 272201800007I-P00002-759302300001-1
- **Recipient organization:** EUROFINS PANLABS, INC.
- **Principal Investigator:** ANTHONY GALLAGHER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $46,800
- **Award type:** —
- **Project period:** 2023-09-11 → 2024-09-11

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11084262

## Citation

> US National Institutes of Health, RePORTER application 11084262, Task E13: Lead Optimization Screening Assays for ADMET, Safety Profiling, Rodent Pharmacokinetics and MTD (272201800007I-P00002-759302300001-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/11084262. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*